Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ISRAEL DISCOUNT BANK LTD. (DSCT)

  • Business News
  • Aug. 13, 2026, 05:06 UTC
  • 2
  • 1 comments

Dividend in the amount of 39.32693 agorot per share, ex-date: 27.8.26, payment 8.9.26

Market reaction Comment Full text

ACMA LTD. (AYV)

  • Business News
  • Aug. 13, 2026, 04:53 UTC
  • 4
  • 1 comments

General Announcement: Use of Proceeds from Share Placement

Market reaction Comment Full text

CHINA AVIATION OIL (SINGAPORE) CORPORATION LTD (G92)

  • Business News
  • Aug. 13, 2026, 04:51 UTC
  • 4
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

ISRAEL DISCOUNT BANK LTD. (DSCT)

  • Business News
  • Aug. 13, 2026, 04:37 UTC
  • 4
  • 1 comments

Q2/half-year report for 2026

Market reaction Comment Full text

DELEK LOGISTICS PARTNERS, LP (DKL)

  • Business News
  • Aug. 13, 2026, 04:27 UTC
  • 4
  • 1 comments

Delek Logistics Partners, LP Announces Pricing of Public Offering of Common Units

Market reaction Comment Full text

PROPNEX LIMITED (OYY)

  • Business News
  • Aug. 13, 2026, 04:21 UTC
  • 4
  • 1 comments

General Announcement: Business Updates for Six Months Ended 30 June 2026

Market reaction Comment Full text

CENTURION CORPORATION LIMITED (OU8)

  • Business News
  • Aug. 13, 2026, 04:16 UTC
  • 4
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

SUTL ENTERPRISE LIMITED (BHU)

  • Business News
  • Aug. 13, 2026, 04:15 UTC
  • 7
  • 1 comments

Change - Change in Corporate Information: Incorporation of Subsidiary

Market reaction Comment Full text

SUTL ENTERPRISE LIMITED (BHU)

  • Business News
  • Aug. 13, 2026, 04:10 UTC
  • 6
  • 1 comments

Financial Statements and Related Announcement: Half Yearly Results

Market reaction Comment Full text

Abcellera Biologics Inc (ABCL)

  • Business News
  • Aug. 13, 2026, 04:05 UTC
  • 5
  • 1 comments

Press Release: AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants

Market reaction Comment Full text
  • Previous
  • 1423
  • 1424
  • 1425
  • 1426
  • 1427
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239534)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin